These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23410910)

  • 1. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema.
    Gordon K; Schulte D; Brice G; Simpson MA; Roukens MG; van Impel A; Connell F; Kalidas K; Jeffery S; Mortimer PS; Mansour S; Schulte-Merker S; Ostergaard P
    Circ Res; 2013 Mar; 112(6):956-60. PubMed ID: 23410910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas.
    Connell FC; Ostergaard P; Carver C; Brice G; Williams N; Mansour S; Mortimer PS; Jeffery S;
    Hum Genet; 2009 Jan; 124(6):625-31. PubMed ID: 19002718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel stop mutation in the vascular endothelial growth factor-C gene (VEGFC) results in Milroy-like disease.
    Balboa-Beltran E; Fernández-Seara MJ; Pérez-Muñuzuri A; Lago R; García-Magán C; Couce ML; Sobrino B; Amigo J; Carracedo A; Barros F
    J Med Genet; 2014 Jul; 51(7):475-8. PubMed ID: 24744435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical variability in a Japanese hereditary lymphedema type I family with an FLT4 mutation.
    Mizuno S; Yamada Y; Yamada K; Nomura N; Wakamatsu N
    Congenit Anom (Kyoto); 2005 Jun; 45(2):59-61. PubMed ID: 15904433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary lymphedema type I associated with VEGFR3 mutation: the first de novo case and atypical presentations.
    Ghalamkarpour A; Morlot S; Raas-Rothschild A; Utkus A; Mulliken JB; Boon LM; Vikkula M
    Clin Genet; 2006 Oct; 70(4):330-5. PubMed ID: 16965327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milroy's primary congenital lymphedema in a male infant and review of the literature.
    Kitsiou-Tzeli S; Vrettou C; Leze E; Makrythanasis P; Kanavakis E; Willems P
    In Vivo; 2010; 24(3):309-14. PubMed ID: 20555004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Splice-Site Mutation in
    Nadarajah N; Schulte D; McConnell V; Martin-Almedina S; Karapouliou C; Mortimer PS; Jeffery S; Schulte-Merker S; Gordon K; Mansour S; Ostergaard P
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30071673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.
    Ghalamkarpour A; Holnthoner W; Saharinen P; Boon LM; Mulliken JB; Alitalo K; Vikkula M
    J Med Genet; 2009 Jun; 46(6):399-404. PubMed ID: 19289394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLT4/VEGFR3 and Milroy disease: novel mutations, a review of published variants and database update.
    Gordon K; Spiden SL; Connell FC; Brice G; Cottrell S; Short J; Taylor R; Jeffery S; Mortimer PS; Mansour S; Ostergaard P
    Hum Mutat; 2013 Jan; 34(1):23-31. PubMed ID: 23074044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel VEGFR3 mutation causes Milroy disease.
    Butler MG; Dagenais SL; Rockson SG; Glover TW
    Am J Med Genet A; 2007 Jun; 143A(11):1212-7. PubMed ID: 17458866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Milroy case with FLT4/VEGFR3 mutation and an unusual skin biopsy.
    Liu NF; Yu ZY; Lou Y; Sun D
    Br J Dermatol; 2019 Jan; 180(1):223-224. PubMed ID: 30169892
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation on the role of biallelic variants in VEGF-C found in a patient affected by Milroy-like lymphedema.
    Mukenge S; Jha SK; Catena M; Manara E; Leppänen VM; Lenti E; Negrini D; Bertelli M; Brendolan A; Jeltsch M; Aldrighetti L
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1389. PubMed ID: 32592340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel FLT4 mutation identified in a patient with Milroy disease.
    DiGiovanni RM; Erickson RP; Ohlson EC; Bernas M; Witte MH
    Lymphology; 2014 Mar; 47(1):44-7. PubMed ID: 25109169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splice-site mutations in VEGFC cause loss of function and Nonne-Milroy-like primary lymphedema.
    Fastré E; Lanteigne LE; Helaers R; Giacalone G; Revencu N; Dionyssiou D; Demiri E; Brouillard P; Vikkula M
    Clin Genet; 2018 Jul; 94(1):179-181. PubMed ID: 29542815
    [No Abstract]   [Full Text] [Related]  

  • 15. Three children with Milroy disease and de novo mutations in VEGFR3.
    Carver C; Brice G; Mansour S; Ostergaard P; Mortimer P; Jeffery S;
    Clin Genet; 2007 Feb; 71(2):187-9. PubMed ID: 17250670
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
    Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
    Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vegfc/Flt4 signalling is suppressed by Dll4 in developing zebrafish intersegmental arteries.
    Hogan BM; Herpers R; Witte M; Heloterä H; Alitalo K; Duckers HJ; Schulte-Merker S
    Development; 2009 Dec; 136(23):4001-9. PubMed ID: 19906867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.
    Spiegel R; Ghalamkarpour A; Daniel-Spiegel E; Vikkula M; A Shalev S
    J Hum Genet; 2006; 51(10):846-850. PubMed ID: 16924388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the conserved sequence of vascular endothelial growth factor receptor 3 leads to primary lymphoedema.
    Dai T; Li B; He B; Yan L; Gu L; Liu X; Qi J; Li P; Zhou X
    J Int Med Res; 2018 Aug; 46(8):3162-3171. PubMed ID: 29896974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
    Chaudary N; Milosevic M; Hill RP
    Gynecol Oncol; 2011 Nov; 123(2):393-400. PubMed ID: 21839498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.